These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2260453)

  • 1. Genotropin 16 IU KabiVial is more convenient than conventional administration systems for children on growth hormone therapy.
    Danielson K; Neumeyer L; Ritzén M
    Acta Paediatr Scand Suppl; 1990; 370():208-11. PubMed ID: 2260453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Administration of growth hormone by disposable preloaded syringes.
    Danielson K; Neumeyer L; Ritzén M
    Acta Paediatr Scand Suppl; 1990; 366():143-6. PubMed ID: 2403003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimum method for administration of biosynthetic human growth hormone: a randomised crossover trial of an Auto Injector and a pen injection system.
    Stanhope R; Albanese A; Moyle L; Hamill G
    Arch Dis Child; 1992 Aug; 67(8):994-7. PubMed ID: 1520018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient evaluation of a new injection pen for growth hormone treatment in children and adults.
    Sjöblom K; Albertsson-Wikland K; Bengtsson BA; Johannsson G; Thorén M; Degerblad M; Savage MO
    Acta Paediatr Suppl; 1995 Sep; 411():63-5. PubMed ID: 8563072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth hormone therapy with a new delivery system.
    Jørgensen JT; Susgaard S
    Indian J Pediatr; 1991; 58 Suppl 1():43-50. PubMed ID: 1824374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simplified growth hormone therapy--first clinical experience with the KabiPen.
    Albertsson-Wikland K
    Acta Paediatr Scand Suppl; 1988; 343():103-6. PubMed ID: 3057801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are needle-free injections a useful alternative for growth hormone therapy in children? Safety and pharmacokinetics of growth hormone delivered by a new needle-free injection device compared to a fine gauge needle.
    Dörr HG; Zabransky S; Keller E; Otten BJ; Partsch CJ; Nyman L; Gillespie BK; Lester NR; Wilson AM; Hyrén C; van Kuijck MA; Schuld P; Schoenfeld SL
    J Pediatr Endocrinol Metab; 2003 Mar; 16(3):383-92. PubMed ID: 12705363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacterial contamination of growth hormone solution and injection equipment during use by growth hormone deficient children.
    Zweens MJ; Drayer NM; Dankert J
    J Hosp Infect; 1991 Jun; 18(2):123-30. PubMed ID: 1678757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient acceptance of Nordiject: a new drug delivery system for growth hormone.
    Jørgensen JT; Mortensen HB; Jørgensen JO
    DICP; 1991 Jun; 25(6):585-8. PubMed ID: 1877265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement of patient convenience in treatment with growth hormone.
    Jørgensen JT
    J Pediatr Endocrinol; 1994; 7(2):175-80. PubMed ID: 8061763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Placebo-controlled, double-blind, cross-over trial of growth hormone treatment in prepubertal children with chronic renal failure.
    Hokken-Koelega AC; Stijnen T; de Muinck Keizer-Schrama SM; Wit JM; Wolff ED; de Jong MC; Donckerwolcke RA; Abbad NC; Bot A; Blum WF
    Lancet; 1991 Sep; 338(8767):585-90. PubMed ID: 1715501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An attempt to assess the replacement dose of human growth hormone in the treatment of growth hormone deficient children.
    Hibi I; Tanaka T; Yano H; Umezawa S; Kagawa J; Tanae A; Ishikawa E
    Acta Paediatr Scand Suppl; 1987; 337():87-92. PubMed ID: 3324640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic effects of growth hormone administered subcutaneously once or twice daily to growth hormone deficient adults.
    Laursen T; Jørgensen JO; Christiansen JS
    Clin Endocrinol (Oxf); 1994 Sep; 41(3):337-43. PubMed ID: 7525120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth-hormone therapy for short children without growth-hormone deficiency.
    Nutr Rev; 1992 Jul; 50(7):199-201. PubMed ID: 1641200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Norditropin SimpleXx: a liquid human growth hormone formulation, a pen system and an auto-insertion device.
    Müller J; Skakkebaek NE; Jacobsen BB; Keller E; Heinrich U; Hartmann K; Hokken-Koelega AC; Delemarre van de Waal HA
    Horm Res; 1999; 51 Suppl 3():109-12. PubMed ID: 10592453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical experience with Genotropin in growth hormone deficient children.
    Wilton P; Gunnarsson R
    Acta Paediatr Scand Suppl; 1988; 343():95-101. PubMed ID: 3057810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ease of use and acceptability of a new pen device for the administration of growth hormone therapy in pediatric patients: an open-label, uncontrolled usability test.
    Fuchs GS; Mikkelsen S; Knudsen TK; Kappelgaard AM
    Clin Ther; 2009 Dec; 31(12):2906-14. PubMed ID: 20110030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth hormone administration by means of an injection pen.
    Jørgensen JO; Møller J; Jensen FS; Jørgensen JT; Christiansen JS
    Pharmacol Toxicol; 1989 Aug; 65(2):96-9. PubMed ID: 2813289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of acute and chronic growth hormone (GH) administration on GH secretion in patients with idiopathic GH deficiency.
    Hanew K; Goh M; Sato S; Shimizu Y; Sasaki A; Aida M; Yoshinaga K
    J Clin Endocrinol Metab; 1988 Apr; 66(4):715-21. PubMed ID: 3126213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of radiation-induced growth hormone deficiency with growth hormone-releasing hormone.
    Ogilvy-Stuart AL; Stirling HF; Kelnar CJ; Savage MO; Dunger DB; Buckler JM; Shalet SM
    Clin Endocrinol (Oxf); 1997 May; 46(5):571-8. PubMed ID: 9231053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.